Overview

Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants

Status:
Completed

Trial end date:
2007-08-23

Target enrollment:

Participant gender:

Summary

This is a study to compare the pharmacokinetic profile of teduglutide in healthy participants with normal hepatic function with participants who have moderate hepatic impairment.

Phase:

Phase 1

Details

Lead Sponsor:

NPS Pharma
Shire

Treatments:

Teduglutide